Bayer sees pharma growth as unit chief touts comeback story

Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales ...
CNBC

Bayer CEO on managing through the good and bad: 'Call out the problems'

Bayer CEO Bill Anderson takes the stage at the 2025 CNBC CEO Council Summit to talk to leaders about managing through uncertainty and tackling problems head-on. Got a confidential news tip? We want to ...
U.S. News & World Report

Bayer Tells US It Could Halt Roundup Weedkiller Sales Over Legal Risks

FRANKFURT (Reuters) -Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation, according to a financial ...
The Business Journals

Bayer CEO: Roundup lawsuits biggest threat to innovation

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In an interview Friday during ...
Seeking Alpha

Bayer is said to consider ending production of Roundup amid legal costs

The future of Roundup, the world’s most widely used herbicide, hangs in the balance as chemical maker Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) signals it may soon halt production unless it receives legal ...
Reuters

Bayer told analysts of cash call plan a day before official statement

FRANKFURT, March 7 (Reuters) - Bayer (BAYGn.DE), opens new tab told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, ...
FierceBiotech

'We are firing on all cylinders': Bayer pharma BD chief says group overhaul not slowing dealmaking

At Bayer, a groupwide restructuring is being rolled out as a top priority. But, to Juergen Eckhardt, M.D., who leads both the investment arm Leaps by Bayer and the pharma business development team, ...